Evidence map›Paper›PMID 39949513›Full record

ArticleFrontiers in pediatrics2024

Risk factors for malignancy in pediatric subacute/chronic focal craniocervical lymphadenopathy.

Yishai Haimi-Cohen, Eyal Elron, Lital Oz-Alcalay, Lama Hejly, Roy Hod, Liat Ashkenazi-Hoffnung

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yishai Haimi-Cohen *Department for Day Hospitalization, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Eyal Elron *Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Lital Oz-AlcalayDepartment of Pediatrics A, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Lama HejlyDepartment for Day Hospitalization, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Roy HodFaculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Liat Ashkenazi-HoffnungDepartment for Day Hospitalization, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: To describe the factors associated with malignancy in otherwise healthy children with focal persistent isolated craniocervical lymphadenopathy at low risk for malignancy, in order to aid in decisions of nodal surgical excision. Material and methods: Demographic and clinical data were retrospectively obtained for children with subacute and chronic craniocervical lymphadenopathy, treated from January 2008 to December 2020 at a general pediatric ambulatory clinic of a tertiary center. Univariate and multivariate analyses of risk factors for malignancy were performed. Results: Of the 450 children included, median age 4.2 years (interquartile age: 2.4-8.7), 25 (5.6%) were eventually diagnosed with a malignancy. In univariate analysis, factors associated with malignancy included older age, increased nodal size, location (supraclavicular and lateral cervical), systemic signs such as decreased appetite and weight loss, and abnormal imaging studies. Referral by an ear, nose, throat specialist vs. a family physician or a pediatrician was also associated with malignancy. Fever, night sweats, pruritus, hepatosplenomegaly and laboratory workup were not associated with malignancy. Twenty percent of the children older than 12.5 years and 12% of those with a lymph node diameter >31 mm were diagnosed with malignancy. Multivariate analysis showed associations with malignancy of older age and larger lymph nodes; the respective odds ratios were 1.649 (95%CI: 1.197-2.349, Conclusions: Older age and increased nodal size can help identify children with focal craniocervical lymphadenopathy who are at increased risk for malignancy and for whom surgical intervention should be strongly considered.

Indexed as

benignbiopsycervical lymphadenopathylymphomamalignancy

Identifiers

PMID39949513
PMCPMC11821598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.